Hello, I'm Pamela Bonnett.

Pamela is a distinguished business executive with over 30 years of leadership experience driving growth and innovation in medical devices​,​ healthcare technology​,​ and software within some of the world's most respected organizations​,​ including GE Healthcare and Envista Dental Holdings. She is a results-driven leader with a strong track record in strategic planning​,​ execution​,​ and commercial excellence​,​ having successfully managed P&Ls ranging from $100M to $1B in revenue. Recognized for her strategic vision and business acumen​,​ Pamela was recruited by Danaher Corporation to help lead the spin-out of its dental business platform​,​ Envista Dental Holdings. She played a pivotal role in its successful IPO launch on the New York Stock Exchange. Her ability to drive business transformation​,​ navigate complex market dynamics​,​ and execute growth strategies has made her an invaluable asset to both public and private organizations. As Board Chair of HerHealthEQ​,​ a nonprofit dedicated to advancing health equity for women in developing communities​,​ Pamela applies her industry expertise to support the acquisition of essential medical equipment for the detection​,​ prevention​,​ and treatment of non-communicable diseases. She also contributes her leadership to BACCH Laboratories​,​ where she leverages her expertise in AI and commercialization to accelerate the adoption of groundbreaking sound technologies​,​ particularly in the advancement of hearing aids. Additionally​,​ she plays a key role at OUTCOMEUS​,​ where she supports the company’s mission to improve the lives of individuals suffering from chronic pain. At Proove Genomics she brings her business acumen to guide the launch of​,​ a molecular diagnostics company pioneering precision pain medicine.company. As the CEO of Ultrasound AI​,​ she led the transformation of a startup into a structured​,​ high-potential organization​,​ driving product development​,​ regulatory compliance​,​ commercialization​,​ and operational excellence. Under her leadership​,​ the company submitted its first product for FDA clearance​,​ with approval expected in 2024. With a career foundation built during her 26-year tenure at GE Healthcare​,​ Pamela has a proven track record of leading profitable business growth across North America. Her expertise in commercial strategy​,​ data-driven decision-making​,​ product viability assessment​,​ and market expansion has consistently delivered successful go-to-market strategies. Her accomplishments have earned her recognition as one of The Top Women in MedTech to Know. Pamela is a dedicated and influential board member​,​ making a profound impact on transformative organizations. She has worked closely with past employer boards​,​ shaping North American commercial strategies and driving business success. As a potential board member​,​ Pamela brings deep expertise in: • Commercialization & Go-to-Market Strategy – Proven ability to develop and execute impactful product launches. • Financial & Operational Acumen – Extensive experience managing large P&Ls and driving business profitability. • Executive Mentorship & Leadership Development – Passion for coaching and mentoring senior leaders to achieve profitable growth. • Scaling & Growth Strategy – Expertise across all stages of business growth​,​ from Fortune 100 corporations to startups and IPOs.